While reading Judy Stecker’s “The FDA Could Help Save My Son From a Rare Disease” (op-ed, Feb. 28), I couldn’t stop thinking about my own children’s battle against a rare disease—and the Food and Drug Administration red tape that kept effective treatment an ocean away.